Cardiovascular Diseases, Cardiovascular Risk Factor
Conditions
Brief summary
This project will examine the diagnosis and prognosis of patients with cardiovascular disease in hospital in- and outpatients and compare their characteristics with normal controls from the community. The cardiovascular diseases studied include coronary artery disease, heart failure, heart attacks, valve disease, cardiac surgery, dysrhythmias, aneurysms, embolism, strokes, peripheral vascular disease and hypertension. Current methods for diagnosis and predicting outcome in patients are limited and may lack accuracy. This study will collect clinical details, and blood and urine samples from patients for analysis of proteins, chemicals and genetic biomarkers which will enable an examination of the pathological mechanisms involved in cardiovascular disease. The data will also be used to improve diagnosis and also improve prediction of outcome in patients (future clinical events such as death, further hospitalisation with cardiovascular disease and the effects of any therapy given to the patients). In this way, we can develop accurate ways of assessing a patient's condition and how it could be effectively managed. The study will last for 20 years.
Interventions
OTHERObservation
Physiological Measurements Patient reported questionnaire Blood sampling
Sponsors
University Hospitals, Leicester
University of Leicester
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* All outpatients and inpatients with cardiovascular disease, of either gender * Aged 18-90 years old * Examples of conditions include: coronary artery disease, heart failure, heart attacks (myocardial infarction), valve disease, cardiac surgery, dysrhythmias (including atrial fibrillation), aneurysms, embolism, strokes, peripheral vascular disease, hypertension (and its complications, such as left ventricular hypertrophy) or those presenting with chest pain * Healthy volunteers * Aged 18-90 years old * From the community without cardiovascular or other diseases
Exclusion criteria
* Any patient who is unable to give consent * Any patient with non-cardiovascular comorbidity likely to cause death within 6 months * Patients know to be infected with HIV, Hepatitis B or any other agent posing an infection risk from unfixed material
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To improve understanding of disease mechanisms in cardiovascular disease | 20 Years | The principal objective is to improve upon our understanding of disease mechanisms in cardiovascular disease, using plasma and urine proteins or chemicals and a patient's genetic makeup, which may impact on the diagnosis and assessment of prognosis of cardiovascular disease. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To improve prediction of responses to different treatments, using blood proteins or chemicals and a patient's genetic makeup | 20 Years | Secondary objectives include predicting response to different treatments (which would include drugs, devices) using blood proteins or chemicals and a patient's genetic makeup, after appropriate matching by propensity scoring. Plus, assessing whether biomarkers in stool or other tissue can discern the presence and severity of coronary artery disease. |
Countries
United Kingdom
Contacts
CONTACTEmma P Beeston
CONTACTTara Maitland
PRINCIPAL_INVESTIGATORNilesh J Samani, Professor
NIHR Leicester Biomedical Research Centre
Outcome results
None listed